Testican-1 as a Biomarker for Assessing Disease Severity in COVID-19 Patients
Objective: This study aimed to evaluate the levels of testican-1 in patients diagnosed with Coronavirus Disease-2019 (COVID-19) and to investigate its potential utility in predicting disease severity and clinical progression. Testican-1, a proteoglycan with known associations with sepsis and central...
| الحاوية / القاعدة: | Global Emergency and Critical Care |
|---|---|
| المؤلفون الرئيسيون: | , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Türkiye Acil Tıp Vakfı
2025-08-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://globemcc.com/articles/testican-1-as-a-biomarker-for-assessing-disease-severityandnbsp-in-covid-19-patients/doi/globecc.galenos.2025.85057 |